Message Font: Serif | Sans-Serif
 
No. of Recommendations: 2
On the most recent quarterly conference call, management is quite clear they intend to run even, or at zero earnings for the next two years. The intention is to plow back what would have been earnings from the existing platforms into new research, technology and scientist resources. The goal is to drive to products that are more downstream in the pharmaceutical development process where higher value lies.

This strategy leaves existing shareholders needing to focus on the longterm since earnings growth rates will shrink in comparison to this past year. I hope the management is deft at marketing the new potential products under development, since that is what will be financed by what would have been earnings.

drejt
Print the post  

Announcements

When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.